
Tetrahedron p. 10229 - 10238 (1997)
Update date:2022-08-04
Topics:
Katoh, Tadashi
Itoh, Etsuko
Yoshino, Toshiharu
Terashima, Shiro
A synthetic strategy for an enantiomeric pair of FR900482 (1) was developed, which features a convergent and enantioselective sequence starting from 5-hydroxyisophthalic acid (16) and each enantiomer of diethyl tartrate (17 and ent-17). The proposed key intermediate 10 was synthesized from FK973 (3), the triacetyl derivative of 1, and successful reconversion of 10 into 1 was also achieved. These preliminary studies definitely demonstrated that 10 is suitable as a potential advanced key intermediate for 1 and that the crucial final sequence of reactions (10→1) involving delicate deprotection and oxidation steps can be realized.
View MoreXinchang Jiu Xin Pharmaceutical Co., Ltd
website:http://www.jiuxinpharm.com
Contact:86 137 5756 8585
Address:Poyang industry Park
Zhejiang Chemicals Import & Export Corporation (ZHECHEM)
Contact:+86-571-87046953
Address:No. 37, Qingchun Road
Nanjing Spring & Autumn Biological Engineering Co., Ltd.
Contact:86-180510-83338
Address:Suite# 210, No. 1 BuildingNanjing Agricultural Biotechnology High-tech Entrepreneurship Center, No. 4 Tongwei Road, Xuanwu District, Nanjing,China
Beijing Cooperate Pharmaceutical Co.,Ltd
website:http://www.cooperate-pharm.com/
Contact:86-01060279497
Address:No.507,Building 4,Tianhua Street, Biomedicine industrial Base
Shanghai Run-Biotech Co., Ltd.
website:http://www.run-biotech.com
Contact:+86-21-31576854/57171705 / 57171706
Address:second floor, building 3, No.999, jiangyue Road, minghang District, Shanghai, China
Doi:10.1016/0040-4020(96)00300-6
(1996)Doi:10.1016/0020-1693(95)04962-2
(1996)Doi:10.1021/ic960072k
(1996)Doi:10.1039/jr9350001088
(1935)Doi:10.1007/s11224-010-9703-x
(2011)Doi:10.1016/j.jorganchem.2013.11.035
(2014)